Search research articles
Contact Us
Filters
Showing results (141-150 of 284) with videos related to
Page
of 29
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2003
Phase II study of imatinib in patients with small cell lung cancer
Bruce E Johnson, Thomas Fischer, Berthold Fischer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 23, 2019
MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation Consortium
Robin Guo, Lynne D Berry, Dara L Aisner, et al.
Academic Radiology
|
November 2, 2010
CT tumor volume measurement in advanced non-small-cell lung cancer: Performance characteristics of an emerging clinical tool
Mizuki Nishino, Mengye Guo, David M Jackman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2009
Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: results of an online tumor registry of clinical trials
David M Jackman, Vincent A Miller, Leigh-Anne Cioffredi, et al.
Future Oncology (London, England)
|
December 17, 2021
Encorafenib plus binimetinib in patients with <i>BRAF</i><sup>V600</sup>-mutant non-small cell lung cancer: phase II PHAROS study design
Gregory J Riely, Myung-Ju Ahn, Enriqueta Felip, et al.
HGG Advances
|
June 21, 2024
Additional impact of genetic ancestry over race/ethnicity to prevalence of KRAS mutations and allele-specific subtypes in non-small cell lung cancer
Xinan Wang, Kangcheng Hou, Biagio Ricciuti, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
July 22, 2009
Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study
Tamara R Tilleman, William G Richards, Lambros Zellos, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 29, 2014
Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer
Ravi B Parikh, Angel M Cronin, David E Kozono, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 27, 2009
Integration of molecular profiling into the lung cancer clinic
William Pao, Mark G Kris, A John Iafrate, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 24, 2022
Safety of image guided research biopsies in patients with thoracic malignancies
Steffan K Soosman, Matthew P Schenker, Emanuele Mazzola, et al.
Page
of 29
Search research articles
Search
Showing results (141-150 of 284) with videos related to
Sort By:
Page
of 29
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2003
Phase II study of imatinib in patients with small cell lung cancer
Bruce E Johnson, Thomas Fischer, Berthold Fischer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 23, 2019
MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation Consortium
Robin Guo, Lynne D Berry, Dara L Aisner, et al.
Academic Radiology
|
November 2, 2010
CT tumor volume measurement in advanced non-small-cell lung cancer: Performance characteristics of an emerging clinical tool
Mizuki Nishino, Mengye Guo, David M Jackman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2009
Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: results of an online tumor registry of clinical trials
David M Jackman, Vincent A Miller, Leigh-Anne Cioffredi, et al.
Future Oncology (London, England)
|
December 17, 2021
Encorafenib plus binimetinib in patients with <i>BRAF</i><sup>V600</sup>-mutant non-small cell lung cancer: phase II PHAROS study design
Gregory J Riely, Myung-Ju Ahn, Enriqueta Felip, et al.
HGG Advances
|
June 21, 2024
Additional impact of genetic ancestry over race/ethnicity to prevalence of KRAS mutations and allele-specific subtypes in non-small cell lung cancer
Xinan Wang, Kangcheng Hou, Biagio Ricciuti, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
July 22, 2009
Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study
Tamara R Tilleman, William G Richards, Lambros Zellos, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 29, 2014
Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer
Ravi B Parikh, Angel M Cronin, David E Kozono, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 27, 2009
Integration of molecular profiling into the lung cancer clinic
William Pao, Mark G Kris, A John Iafrate, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 24, 2022
Safety of image guided research biopsies in patients with thoracic malignancies
Steffan K Soosman, Matthew P Schenker, Emanuele Mazzola, et al.
Page
of 29